Barak's Push into Gemel and Insurance: Value Creation or Expansion Ahead of Capital
Barak has already opened the path into gemel, pension insurance, and alternative investments, but as of the report date the move still rests mainly on licensing, planned capital injections, and controller-linked agreements. With equity at only NIS 1.424 million, the real question is no longer whether there is a strategy, but whether the capital base arrived in time.
The main article already established that Barak's 2025 earnings improvement still rested on a narrow core. This continuation isolates the next junction in the story: the company is no longer just a small investment house selling funds and portfolios. It is trying to build a broader platform in gemel, pension insurance, and alternative investments. The key question is not whether that strategic direction is interesting. It is. The question is whether the expansion already rests on proven economics and accumulated capital, or whether it is moving one step ahead of the balance sheet.
To read that correctly, two sets of numbers have to be held together. On one side, the group generated NIS 1.528 million of operating profit in 2025, NIS 1.443 million of operating cash flow, and ended the year with NIS 1.087 million of cash and cash equivalents plus NIS 1.987 million of short-term investments. On the other side, equity stood at only NIS 1.424 million, the accumulated deficit still amounted to NIS 29.095 million, and Barak Gemel is expected to rely, among other things, on a roughly NIS 3 million capital injection from Tomer Haim and Yosef Herman and on planned bank financing of about NIS 12 million that still has no binding agreement behind it.
That is the heart of this continuation. Barak's expansion looks like the construction of a broader financial platform, but as of the report date it still rests on three pillars that have not yet been proved: licensing, planned financing, and controller-linked operating structures. This is not yet proof of value creation. It is mainly the setup for the possibility of future value creation.
Three New Engines, Still Without a Proven Earnings Layer
Barak has already opened three expansion lanes. The first is alternative investments, through Barak Alternative Investments, a wholly owned subsidiary that serves as the general partner of a hedge fund. The second is pension insurance distribution, through a wholly owned subsidiary that is still in the licensing process. The third is Barak Gemel, a new private company for provident-fund management in which Barak will hold 70%, while the balance will be split among Shay Barak, Tomer Haim, and Yosef Herman.
What ties all three together is that they already exist at the legal and strategic level, but not yet at the level of proven revenue.
| Activity | What already exists | What has been proved economically through year-end 2025 | What is still open |
|---|---|---|---|
| Alternative investments | A wholly owned subsidiary received the general partner rights in Prodigy Capital Fund LP | The fund holds about USD 3.5 million of assets, and the general partner is entitled to a 2% management fee and 20% performance fee after expenses, but no revenue was recognized in 2025 and none was recognized in 2023 or 2024 by the previous general partner | First actual revenue from management or performance fees |
| Pension insurance | The insurance agency has already been formed and is in licensing | A services agreement was approved with a company controlled by Tomer Haim, for a monthly fee of NIS 95 thousand plus VAT | License, operating launch, and proof that the cost turns into revenue |
| Barak Gemel | The company has been formed, and Barak will hold 70% of the issued and paid-up capital | There is still no operating track record or revenue, and funding is described as expected to come from equity injection and future bank debt | Permit and license, binding financing, and actual commercial launch |
The alternative-investments activity is the first clear example of what should worry readers here. In August 2025, the controlling shareholders transferred the general partner activity in the hedge fund to the company as a qualifying transaction, and from that point Barak Alternative Investments became entitled to management and performance fees. On paper, that sounds like a new profit engine. In practice, no revenue was recognized from that right in 2025, and no such revenue had been recognized by the previous general partner in 2023 or 2024 either. In other words, Barak received an economic option, but not yet evidence that the option is monetizing.
Insurance and gemel sit at the same stage. The company estimates that Barak Gemel will receive its permit and license during the coming year, and that the insurance agency will receive its license during the second quarter of 2026. Those are important milestones, but they are not yet operating proof. They are still preconditions for testing whether a real revenue engine exists.
This chart matters because it reminds the reader that gemel is not simply an internal extension of the listed company. Even if Barak Gemel succeeds, not all of that future value will sit 100% inside Barak. The public company will hold 70%, and the rest has already been allocated directly to controlling parties.
The Capital Base Still Does Not Look Like a Platform That Can Fund the Leap On Its Own
The report can be read in two ways. The comfortable reading says the company has already turned operating profit positive, generated positive operating cash flow, and has enough resources for the next 12 months. That is indeed management's position. The sharper reading says this is still a very thin capital base relative to the scale of the planned expansion. Both readings are true at the same time, and the tension between them is exactly the story.
At year-end 2025 the group had NIS 1.087 million of cash and cash equivalents and NIS 1.987 million of short-term investments, or about NIS 3.074 million of gross liquidity. Against that stood NIS 3.130 million of current liabilities, including NIS 1.281 million of income tax payable. Equity, as noted, was only NIS 1.424 million. This is not a picture of immediate cash distress, but it is also not a picture of obvious excess capital that can easily absorb new regulated operating lines.
This chart does not place all of those figures into one accounting bridge, but it does clarify scale. The planned funding for Barak Gemel is larger than the group's existing equity base, and the bank financing Barak hopes to obtain for it sits in a completely different order of magnitude from the current structure. That is not a technical footnote. At the end of 2025 the group's reported bank credit stood at NIS 211 thousand short term and NIS 146 thousand long term. So a planned facility of about NIS 12 million for Barak Gemel is not a natural extension of what already exists. It is a jump to a new financing tier.
The wording in the filing matters as well. Barak Gemel is expected to be funded, among other things, by an equity injection of about NIS 3 million from Tomer Haim and Yosef Herman, and the company intends to enter into a bank financing arrangement for about NIS 12 million. Barak says it received a positive indication from the bank, but explicitly adds that no binding credit agreement exists yet. So the financing leg of the expansion thesis is still not closed. It is at the stage of intention and progress, not at the stage of already secured capital.
That point becomes even more important when the auditor's framing is added. The audit report flagged management's cash flow forecast and plans to meet obligations in the foreseeable future as a key audit matter against the backdrop of the accumulated deficit, while management states that available sources are sufficient for the coming 12 months. That is a clear sign that funding capacity is not a side discussion. It already belongs in the core reading of the accounts.
So anyone reading the push into gemel and insurance as if it is already funded out of accumulated operating surplus is reading the situation too generously. What Barak actually has is a shift from the thesis of a small investment house becoming more profitable, to the thesis of a financial platform that now needs capital, licensing, and financing coordination in order to prove itself.
Controller-Linked Agreements Are Not a Footnote, They Are Part of the Buildout
The common thread between gemel, insurance, and alternative investments is not only the desire to expand. It is also the fact that much of the infrastructure is being built through controlling-shareholder transactions or compensation layers that tie directly into future profit.
In the alternative-investments activity, the general partner rights came into the company through a transfer from controlling shareholders. In insurance, the setup and early operation of the agency rely on a services agreement with a company controlled by Tomer Haim, the chairman and one of the controlling shareholders, for a monthly fee of NIS 95 thousand plus VAT. In gemel, the listed company itself will hold only 70%, with the balance sitting directly with controlling parties. And in compensation, the compensation committee and the board already approved in March 2026 a bonus equal to 5% of pre-tax profit at Barak Gemel and Barak Mutual Funds for the chairman and CEO, effective from 2025, above the ceiling set in the compensation policy and subject to general meeting approval.
| Layer | What was approved | Why it matters for value capture |
|---|---|---|
| Alternative investments | The general partner rights were transferred from controlling shareholders to the company as a qualifying transaction | The new engine came in through a controller-linked deal before it proved it can generate revenue |
| Pension insurance | A services agreement with a company controlled by the chairman, at NIS 95 thousand per month plus VAT | The operating layer is already defined as a meaningful fixed cost before there is proven activity |
| Barak Gemel | The company will hold only 70%, with 30% allocated to controlling shareholders | Even if value is created, not all of it will sit inside the listed company |
| Chairman and CEO compensation | 5% of pre-tax profit at Barak Gemel and Barak Mutual Funds, above policy ceiling and subject to shareholder approval | Part of the future upside is already earmarked for compensation before the new units have shown recurring earnings |
This should be said precisely. The existence of controller-linked agreements is not itself proof of a conflict or of value destruction. But in Barak's case it is also not background noise. It is part of the expansion architecture. Before there are licenses, clients, and recurring revenue, there is already a partial ownership structure, a related-party service provider, and compensation rights tied directly to pre-tax profit in the new or expanded lines.
That changes the success test. Barak will not only need to prove that it can enter new lines of business. It will need to prove that after ownership sharing, service layers, and incentive structures, enough value still remains inside the listed company for public shareholders.
What Has To Happen Next For This To Count As Value Creation Rather Than Premature Stretch
For now, 2026 is better read as a proof year for the expansion move. Not a breakout year, and not yet a monetization year. A proof year. The reason is simple: none of the three new legs has yet shown recurring earnings at a scale that justifies the width of the story.
The first test is regulatory. The insurance agency needs to receive its license during the second quarter of 2026 as the company expects, and Barak Gemel needs to receive its permit and license during the coming year. Without that, any talk about synergy between funds, gemel, and insurance remains a platform narrative on paper.
The second test is financing. A positive bank indication is still not funding, and a planned equity injection is still not capital already built into the public company. If Barak Gemel closes financing on workable terms and begins operating without overloading the existing structure, that will be an important step. If financing is delayed, becomes expensive, or requires the listed company to stretch its capital base even further, the whole expansion story will have to be resized back to its real economic scale.
The third test is accessible value. In alternative investments, the company needs to show first revenue from management or performance fees. In insurance, it needs to show that the services agreement translates into clients and income rather than only into startup overhead. In gemel, it will not be enough to show an operating launch. Barak will need to show what share of the value actually remains after the ownership split, the service structure, and the compensation layer.
That is precisely the difference between strategic expansion and value creation. Strategic expansion can be described even before profit exists. Value creation has to be measured in cash, net earnings, and what remains inside the listed company after all surrounding layers are paid.
Conclusion
At the level of direction, Barak is doing the right thing. A small investment house that still leans heavily on mutual funds cannot stay one-dimensional forever, and the move into gemel, insurance, and alternative investments is a reasonable attempt to broaden the platform. But as of the report date, this is still an expansion that runs ahead of the capital base more than it proves value has already been built.
The current continuation thesis is straightforward: Barak does not lack vision, it still lacks proof. Equity is small, part of the future funding stack is not yet binding, and the new lanes are already wrapped in controller-linked ownership, service, and compensation structures before they have shown recurring profit. That does not mean the strategy will fail. It does mean the market should measure it far more carefully than the headline of "entry into new lines of activity."
If over the next two to four quarters the company receives the licenses, closes binding financing for Barak Gemel, and shows first revenue from the new activities without letting the related layers absorb most of the upside, this reading will improve quickly. If the expansion remains mostly a story of agreements, indications, and intentions, Barak will look less like a financial platform being built and more like a listed company moving into execution before it has fully built the capital underneath it.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.